Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

3-Hydroxybutyric acid (sodium)

3-Hydroxybutyric acid sodium (β-Hydroxybutyric acid sodium) is a metabolite that is elevated in type I diabetes. 3-Hydroxybutyric acid sodium can modulate the properties of membrane lipids[1].

Product Specifications

CAS Number

[150-83-4]

Product Name Alternative

β-Hydroxybutyric acid (sodium)

UNSPSC

12352211

Hazard Statement

H302

Target

Endogenous Metabolite

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

Metabolism-sugar/lipid metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/3-hydroxybutyric-acid-sodium.html

Purity

99.82

Solubility

DMSO : 16.67 mg/mL (ultrasonic; warming; heat to 60°C) |H2O : 25 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

CC(O)CC(O[Na])=O

Molecular Formula

C4H7NaO3

Molecular Weight

126.09

Precautions

H302

References & Citations

[1]Hsu TT, et al. 3-Hydroxybutyric acid interacts with lipid monolayers at concentrations that impair consciousness. Langmuir. 2013 Feb 12;29 (6) :1948-55.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

Human Endogenous Metabolite

Citation 01

BMC Neurol. 2025 Apr 10;25 (1) :153.|Research Square Preprint. 2024 Aug 08.|Acta Pharm Sin B. 2025 Mar;15 (3) :1430-1446.|Biochem Biophys Res Commun. 2024 Jul 25:734:150449.|Cancer Cell. 2024 Oct 14;42 (10) :1729-1746.e8.|Cell Host Microbe. 2024 Dec 12:S1931-3128 (24) 00444-X.|Cell Metab. 2023 Jan 3;35 (1) :200-211.e9.|Cells. 2022 Sep 25;11 (19) :2987.|Free Radic Biol Med. 2025 Oct 23:241:914-932.|J Nanobiotechnology. 2022 Mar 9;20 (1) :120.|J Nutr Biochem. 2023 Aug:118:109335.|J Pathol. 2025 Oct 23.|Mol Cell. 2023 Sep 7;83 (17) :3171-3187.e7.|Nat Commun. 2025 May 7;16 (1) :4224.|Nat Metab. 2025 Jul;7 (7) :1330-1343.|Nat Protoc. 2024 May;19 (5) :1311-1347.|Pharmaceuticals (Basel) . 2025 Feb 6;18 (2) :219.|Redox Biol. 2024 May 16.|Signal Transduct Target Ther. 2024 Dec 30;9 (1) :367.

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

Lentiviral human CHAT shRNA (UAS) - Lentiviral human CHAT shRNA (UAS) (25)
GTR15155381 1 Vial

Lentiviral human CHAT shRNA (UAS) - Lentiviral human CHAT shRNA (UAS) (25)

Sign In for Pricing
View Details
PLGA (50:50) (50,000) -b-mPEG (1,500), Diblock polymer, Powder
50349-5 5 g

PLGA (50:50) (50,000) -b-mPEG (1,500), Diblock polymer, Powder

Sign In for Pricing
View Details
SF750 Phalloidin (Far Red)
CA1780 300 Tests

SF750 Phalloidin (Far Red)

Sign In for Pricing
View Details
DAGLB, ID (DAGLB, Sn1-specific diacylglycerol lipase beta, KCCR13L) (APC) discontinued
034463-APC 200 µL

DAGLB, ID (DAGLB, Sn1-specific diacylglycerol lipase beta, KCCR13L) (APC) discontinued

Sign In for Pricing
View Details
Human MTHFD1 siRNA
abx903379-01 15 nmol

Human MTHFD1 siRNA

Sign In for Pricing
View Details
Human MTHFD1 siRNA
abx903379-02 30 nmol

Human MTHFD1 siRNA

Sign In for Pricing
View Details